FDA
approval
· 2018-11-16
FDA Approved: ELAPRASE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
The FDA approved a supplemental application for Elaprase (idursulfase) by Takeda Pharmaceuticals America, Inc., related to changes or additions to the product l…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ELAPRASE (IDURSULFASE)